| scholarly article | Q13442814 |
| P50 | author | Meyer Michel Samama | Q51732700 |
| Patrick Van Dreden | Q51732717 | ||
| P2093 | author name string | Meyer Michel Samama | |
| Eli Karavaggeli | |||
| Grigoris T Gerotziafas | |||
| John Christakis | |||
| Kostas Zervas | |||
| Pantelis Arzoglou | |||
| Patrick Van Dreden | |||
| Stella Parashou | |||
| P2860 | cites work | High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. | Q33338284 |
| Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage | Q33341446 | ||
| Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors | Q45871850 | ||
| Platelet activity of high-dose factor VIIa is independent of tissue factor | Q45884609 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| internal bleeding | Q2361887 | ||
| P304 | page(s) | 705-708 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation | |
| P478 | volume | 117 |
| Q34101751 | Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature |
| Q45877685 | Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors |
| Q47642467 | Fish as bioreactors: transgene expression of human coagulation factor VII in fish embryos. |
| Q50485037 | Intrapulmonary rFVIIa for life threatening pulmonary hemorrhage in a case of relapsing acute lymphoblastic leukemia and platelet refractoriness. |
| Q35839531 | Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding |
| Q33382741 | Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias |
| Q45869094 | The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies |
| Q39089390 | The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: Diagnostic value and analytical usefulness in various pathophysiological states |
| Q34513276 | Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study |
| Q50664916 | Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. |
Search more.